Drugs that contain Propranolol Hydrochloride

1. List of Hemangeol drug patents

HEMANGEOL's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8338489 PIERRE FABRE DERMA Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Oct, 2028

(5 years from now)

US8987262 PIERRE FABRE DERMA Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Oct, 2028

(5 years from now)

Market Authorisation Date: 14 March, 2014

Treatment: Method to treat hemangioma.; Method to treat infantile hemangioma

Dosage: SOLUTION;ORAL

How can I launch a generic of HEMANGEOL before it's patent expiration?
More Information on Dosage

HEMANGEOL family patents

7

United States

3

European Union

2

Denmark

2

Hong Kong

2

Slovenia

2

Croatia

2

Portugal

2

Cyprus

2

Spain

2

Korea, Republic of

2

Poland

2

China

1

Israel

IB

1

IB

1

Austria

1

Mexico

1

Australia

1

Saudi Arabia

1

Russia

1

Morocco

1

Germany

1

Argentina

1

Colombia

1

Brazil

1

Malaysia

1

Chile

1

Taiwan, Province of China

1

Japan

1

Canada

1

Tunisia

1

Panama

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in